Keizo Koya, Senior VP, Drug Development at SYNTA PHARMACEUTICALS CORP (SNTA), sold 6,844 shares at $4.70 ($32K) on 2012-03-01, disclosed to the SEC on 2012-03-05.
Scheduled sale ($32k) by Senior VP, Drug Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SNTA | BUY | 2009-08-26 | $28K | — | Filing → |